nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

28.10.2023 | Head and Neck

Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma

verfasst von: L. López, P. García-Cabo, J. L. Llorente, F. López, J. P. Rodrigo

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Salvage surgery is mandatory when regional persistence/recurrence after chemoradiation. The aim of this study is to describe the outcomes of salvage surgery.

Methods

A retrospective study was conducted in patients with locally advanced head and neck squamous cell carcinoma that were primarily treated with chemorradiation and underwent salvage neck dissection (ND) with suspected recurrent/persistent nodal disease. All patients had a response evaluation at 12 weeks through clinical examination and computed tomography-positron emission tomography. Decision for ND was taken in case of suspected persistence or if there was suspicion of recurrence, histologically confirmed.

Results

There were 40 patients included. 32/40 (80%) ND were done because of confirmed/suspected persistence and 8/40 (20%) were done because of recurrences. Persistence was confirmed histologically in 14/32 (43.8%) cases and recurrence in 6/8 (75%) cases. Median survival from diagnosis was 39 months (95% CI 28.162–49.838). Significant differences were observed between patients who had viable tumour cells in the sample and those who did not, but the differences were only significant when only deaths due to tumour progression were considered (p = 0.014). 14/32 (43.8%) patients with suspected or confirmed persistence developed a recurrence after the ND and 3/8 (37.5%) patients with suspected or confirmed recurrence developed a new recurrence. New recurrences were more frequent in cases that had viable tumor in the specimen.

Conclusions

Patients with nodal persistence/recurrence have a poor prognosis, even after salvage surgery. However, in a substantial number of patients the disease is controlled after ND, so it should be offer to these patients.

Braakhuis BJM, Brakenhoff RH, Leemans CR (2012) Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors. Ann Oncol 10:x173-177. https://doi.org/10.1093/annonc/mds299CrossRef

Machiels J-P, Lambrecht M, Hanin F-X et al (2014) Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep. 6:44. https://doi.org/10.12703/P6-44CrossRefPubMedPubMedCentral

Network NCCN (2022) NCCN Clinical Practice Guidelines in Oncology—Head and Neck Cancers Version 1.2023. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf . Accessed 12 May 2023

Bulbul MG, Genovese TJ, Hagan K et al (2022) Salvage surgery for recurrent squamous cell carcinoma of the head and neck: systematic review and meta-analysis. Head Neck 44:275–285. https://doi.org/10.1002/hed.26898CrossRefPubMed

Ho AS, Kraus DH, Ganly I et al (2014) Decision making in the management of recurrent head and neck cancer. Head Neck 36:144–151. https://doi.org/10.1002/hed.23227CrossRefPubMed

Mehanna H, Wong W-L, McConkey CC et al (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374:1444–1454. https://doi.org/10.1056/NEJMoa1514493CrossRefPubMed

Machiels J-P, Leemans CR, Golusinski W et al (2020) Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol 31:1462–1475. https://doi.org/10.1016/j.annonc.2020.07.011CrossRefPubMed

Patil VM, Noronha V, Thiagarajan S et al (2020) Salvage surgery in head and neck cancer: does it improve outcomes? Eur J Surg Oncol 46:1052–1058. https://doi.org/10.1016/j.ejso.2020.01.019CrossRefPubMed

Goguen LA, Chapuy CI, Li Y et al (2010) Neck dissection after chemoradiotherapy: timing and complications. Arch Otolaryngol Head Neck Surg 136:1071–1077. https://doi.org/10.1001/archoto.2010.188CrossRefPubMed

10.

Henneman R, Rouwenhorst L, Karakullukcu MB et al (2023) Surgical site complications of isolated salvage neck dissection post-radiotherapy and post-chemoradiotherapy—a cohort analysis (1997–2017). Eur J Surg Oncol 49:764–770. https://doi.org/10.1016/j.ejso.2022.12.010CrossRefPubMed

11.

van Weert S, Leemans CR (2021) Salvage surgery in head and neck cancer. Oral Dis 27:117–124. https://doi.org/10.1111/odi.13582CrossRefPubMed

12.

Liauw SL, Mancuso AA, Amdur RJ et al (2006) Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 24:1421–1427. https://doi.org/10.1200/JCO.2005.04.6052CrossRefPubMed

13.

Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247. https://doi.org/10.1016/j.ejca.2008.10.026CrossRefPubMed

14.

Ferrari C, Santo G, Mammucci P et al (2023) [18F]FDG PET/CT in head and neck squamous cell carcinoma: a head-to-head between visual point-scales and the added value of multi-modality imaging. BMC Med Imaging 23:34. https://doi.org/10.1186/s12880-023-00989-5CrossRefPubMedPubMedCentral

15.

Marcus C, Ciarallo A, Tahari AK et al (2014) Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes. J Nucl Med 55:1411–1416. https://doi.org/10.2967/jnumed.113.136796CrossRefPubMed

16.

Robbins KT, Clayman G, Levine PA et al (2002) Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128:751–758. https://doi.org/10.1001/archotol.128.7.751CrossRefPubMed

17.

Patel S, Shah JP, American Joint Committee on Cancer (2010) Part II: head and neck sites. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) AJCC cancer staging manual, 7th edn. Springer, New York, pp 21–100

18.

Rodrigo JP, Heideman DAM, García-Pedrero JM et al (2014) Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990–2009). Int J Cancer 134:487–492. https://doi.org/10.1002/ijc.28355CrossRefPubMed

19.

Lupato V, Giacomarra V, Alfieri S et al (2022) Prognostic factors in salvage surgery for recurrent head and neck cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 169:103550. https://doi.org/10.1016/j.critrevonc.2021.103550CrossRefPubMed

20.

Deschamps DR, Spencer HJ, Kokoska MS et al (2010) Implications of head and neck cancer treatment failure in the neck. Otolaryngol Head Neck Surg 142:722–727. https://doi.org/10.1016/j.otohns.2010.01.026CrossRefPubMed

21.

Chung E-J, Jeong W-J, Jung YH et al (2019) Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: multicenter review of 266 cases. Oral Oncol 89:84–94. https://doi.org/10.1016/j.oraloncology.2018.12.015CrossRefPubMed

22.

Thariat J, Ang KK, Allen PK et al (2012) Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82:e367-374. https://doi.org/10.1016/j.ijrobp.2011.03.062CrossRefPubMedPubMedCentral

23.

Corry J, Peters L, Fisher R et al (2008) N2–N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck 30:737–742. https://doi.org/10.1002/hed.20769CrossRefPubMed

24.

Nayak JV, Walvekar RR, Andrade RS et al (2007) Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 117:2129–2134. https://doi.org/10.1097/MLG.0b013e318149e6bcCrossRefPubMed

25.

You H, Subramaniam RM (2022) PET/Computed Tomography: post-therapy follow-up in head and neck cancer. PET Clin 17(2):319–326. https://doi.org/10.1016/j.cpet.2021.12.001CrossRefPubMed

26.

Dejaco D, Uprimny C, Widmann G et al (2020) Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer—does additional [18F]FDG-PET-CT help? Cancer Imaging 20:69. https://doi.org/10.1186/s40644-020-00345-8CrossRefPubMedPubMedCentral

27.

Elbers JBW, Al-Mamgani A, van den Brekel MWM et al (2019) Salvage surgery for recurrence after radiotherapy for squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 160:1023–1033. https://doi.org/10.1177/0194599818818443CrossRefPubMed

28.

Akali NR, Buggaveeti R, Sukumaran SV et al (2021) Prior chemoradiotherapy and pathological perineural invasion predict the survival outcomes of salvage surgery in head and neck squamous cell carcinoma. Head Neck 43:874–883. https://doi.org/10.1002/hed.26547CrossRefPubMed

29.

Okano W, Hayashi R, Matsuura K et al (2021) Extent of salvage neck dissection following chemoradiation for locally advanced head and neck cancer. Head Neck 43:413–418. https://doi.org/10.1002/hed.26494CrossRefPubMed

30.

Traynor SJ, Cohen JI, Gray J et al (1996) Selective neck dissection and the management of the node-positive neck. Am J Surg 172:654–657. https://doi.org/10.1016/s0002-9610(96)00296-6CrossRefPubMed

31.

Teymoortash A, Hoch S, Eivazi B, Werner JA (2010) Postoperative morbidity after different types of selective neck dissection. Laryngoscope. 120:924–9. https://doi.org/10.1002/lary.20894CrossRefPubMed

32.

Nagasaka M, Zaki M, Issa M et al (2017) Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck. Laryngoscope 127:2260–2264. https://doi.org/10.1002/lary.26554CrossRefPubMedPubMedCentral

Titel: Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma
verfasst von: L. López
P. García-Cabo
J. L. Llorente
F. López
J. P. Rodrigo
Publikationsdatum: 28.10.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2024
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-023-08315-z

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2024

Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis

Meludia platform as a tool to evaluate music perception in pediatric and adult cochlear implant users

Significance of endolymphatic sac surgery with and/or without simultaneous cochlea implant surgery in respect of vertigo control and speech perception in patients with Menière’s disease

Examining otolaryngologists’ attitudes towards large language models (LLMs) such as ChatGPT: a comprehensive deep learning analysis

Validity and reliability of the Group for Learning Useful and Performant Swallowing (GLUPS) tool

A validation study of the 30-day questionnaire in the national Norwegian Tonsil Surgery Register: can we trust the data reported by the patients?

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO